X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6576) 6576
Publication (253) 253
Newsletter (115) 115
Book Review (44) 44
Magazine Article (9) 9
Book Chapter (6) 6
Conference Proceeding (3) 3
Dissertation (2) 2
Newspaper Article (2) 2
Book / eBook (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (3986) 3986
captopril (3563) 3563
humans (3435) 3435
animals (2686) 2686
female (2434) 2434
captopril - pharmacology (2177) 2177
rats (1945) 1945
blood pressure - drug effects (1803) 1803
middle aged (1802) 1802
captopril - therapeutic use (1511) 1511
adult (1476) 1476
captopril - administration & dosage (1357) 1357
hypertension - drug therapy (1309) 1309
aged (1203) 1203
pharmacology & pharmacy (1172) 1172
angiotensin-converting enzyme inhibitors - pharmacology (1011) 1011
hypertension (1010) 1010
angiotensin-converting enzyme inhibitors - therapeutic use (865) 865
cardiac & cardiovascular systems (848) 848
renin - blood (742) 742
index medicus (729) 729
proline - analogs & derivatives (698) 698
time factors (645) 645
heart failure - drug therapy (644) 644
hypertension - physiopathology (625) 625
angiotensin-converting enzyme inhibitors - administration & dosage (623) 623
enalapril (617) 617
hemodynamics - drug effects (610) 610
angiotensin (607) 607
dose-response relationship, drug (569) 569
drug therapy, combination (526) 526
angiotensin-converting enzyme inhibitors (518) 518
peripheral vascular disease (512) 512
double-blind method (483) 483
blood pressure (479) 479
renin-angiotensin system - drug effects (477) 477
heart rate - drug effects (474) 474
captopril - adverse effects (465) 465
blood-pressure (420) 420
rats, inbred strains (412) 412
rats, wistar (408) 408
mortality (402) 402
ace inhibitors (399) 399
administration, oral (389) 389
renin-angiotensin system (389) 389
antihypertensive agents - pharmacology (370) 370
rats, sprague-dawley (360) 360
antihypertensive agents - therapeutic use (356) 356
physiology (348) 348
angiotensin-converting enzyme (343) 343
rats, inbred shr (322) 322
aldosterone - blood (315) 315
heart failure - physiopathology (312) 312
kidney - drug effects (311) 311
heart failure (306) 306
treatment outcome (299) 299
angiotensin ii (298) 298
antihypertensive agents - administration & dosage (298) 298
medicine, general & internal (295) 295
myocardial infarction - drug therapy (286) 286
angiotensin ii - pharmacology (279) 279
enzymes (275) 275
losartan (274) 274
mice (274) 274
therapy (272) 272
drug therapy (268) 268
renin (258) 258
dogs (254) 254
heart-failure (254) 254
angiotensin-converting enzyme inhibitors - adverse effects (248) 248
angiotensin-ii (244) 244
physiological aspects (244) 244
adolescent (240) 240
survival (240) 240
inhibition (235) 235
bradykinin (234) 234
research (233) 233
hypertension - blood (228) 228
system (225) 225
disease models, animal (223) 223
angiotensin receptor antagonists (220) 220
drug administration schedule (217) 217
urology & nephrology (217) 217
myocardial-infarction (216) 216
hemodynamics (215) 215
vascular resistance - drug effects (213) 213
enalapril - pharmacology (207) 207
rat (206) 206
renal circulation - drug effects (205) 205
angiotensin ii - blood (204) 204
cardiovascular system (198) 198
renin-angiotensin system - physiology (198) 198
disease (196) 196
clinical trials as topic (195) 195
in vitro techniques (195) 195
medicine, research & experimental (192) 192
enalapril - therapeutic use (190) 190
angiotensin converting enzyme (182) 182
biochemistry & molecular biology (181) 181
converting enzyme-inhibition (179) 179
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6205) 6205
German (76) 76
French (71) 71
Russian (68) 68
Japanese (58) 58
Italian (55) 55
Spanish (50) 50
Polish (31) 31
Chinese (25) 25
Portuguese (21) 21
Hungarian (9) 9
Czech (6) 6
Danish (5) 5
Korean (5) 5
Romanian (4) 4
Croatian (3) 3
Hebrew (3) 3
Serbian (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Slovak (2) 2
Swedish (2) 2
Turkish (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Heart Failure, ISSN 1388-9842, 08/2005, Volume 7, Issue 5, pp. 710 - 721
Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of... 
Heart failure | Isosorbide dinitrate | Beta‐blockers | Digoxin | Angiotensin receptor blockers | Pharmacology | Aldosterone antagonists | Treatment | Eplerenone | Spironolactone | Hydralazine | ACE inhibitors | Clinical recommendations | Beta-blockers | VENTRICULAR SYSTOLIC DYSFUNCTION | heart failure | treatment | CARDIAC & CARDIOVASCULAR SYSTEMS | angiotensin receptor blockers | QUALITY-OF-CARE | hydralazine | eplerenone | isosorbide dinitrate | RANDOMIZED INTERVENTION TRIAL | beta-blockers | MEDICAL-TREATMENT | GENERAL-PRACTICE | digoxin | spironolactone | CONVERTING-ENZYME-INHIBITORS | clinical recommendations | CARDIAC-INSUFFICIENCY | pharmacology | NATIONAL-SURVEY | aldosterone antagonists | ELDERLY-PATIENTS | Benzopyrans - therapeutic use | Valsartan | Angiotensin Receptor Antagonists | Bisoprolol - therapeutic use | Humans | Carbazoles - administration & dosage | Heart Failure - physiopathology | Valine - administration & dosage | Enalapril - therapeutic use | Ethanolamines - administration & dosage | Indoles - administration & dosage | Ramipril - administration & dosage | Captopril - therapeutic use | Propanolamines - therapeutic use | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Ramipril - therapeutic use | Drug Therapy, Combination | Enalapril - administration & dosage | Spironolactone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Benzimidazoles - therapeutic use | Lisinopril - administration & dosage | Nebivolol | Valine - analogs & derivatives | Metoprolol - therapeutic use | Metoprolol - administration & dosage | Evidence-Based Medicine | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Bisoprolol - administration & dosage | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Benzopyrans - administration & dosage | Captopril - administration & dosage | Guideline Adherence | Ethanolamines - therapeutic use | Indoles - therapeutic use | Metoprolol - analogs & derivatives | Tetrazoles - therapeutic use | Valine - therapeutic use | Carbazoles - therapeutic use | Propanolamines - administration & dosage | Practice Guidelines as Topic | Prescription writing | Corticosteroids | Isosorbide mononitrate | Family medicine | Nitrates | Peptide hormones | Aldosterone | Preventive health services | Cardiac patients | Angiotensin | Antiandrogens | Medicine, Preventive | Steroids | Kardiologi | converting-enzyme-inhibitors | Cardiac and Cardiovascular Systems | randomized intervention trial | quality-of-care | elderly-patients | cardiac-insufficiency | national-survey | medical-treatment | ventricular systolic dysfunction | general-practice
Journal Article
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2006, Volume 47, Issue 4, pp. 726 - 733
OBJECTIVES: We attempted to compare the effect of an angiotensin-converting enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) on atherosclerotic... 
MORTALITY | CHRONIC HEART-FAILURE | HIGH-RISK PATIENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT-VENTRICULAR DYSFUNCTION | CARDIOVASCULAR EVENTS | II TYPE-1 RECEPTOR | RANDOMIZED-TRIAL | CONVERTING-ENZYME INHIBITOR | HYPERTENSIVE PATIENTS | BASE-LINE CHARACTERISTICS | Recurrence | Valsartan | Angina Pectoris - prevention & control | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Valine - administration & dosage | Captopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Tetrazoles - administration & dosage | Cardiovascular Diseases - mortality | Female | Drug Therapy, Combination | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Stroke - prevention & control | Valine - analogs & derivatives | Atherosclerosis - complications | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Randomized Controlled Trials as Topic | Disease-Free Survival | Myocardial Infarction - complications | Captopril - administration & dosage | Myocardial Infarction - drug therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Myocardial Infarction - prevention & control | Heart attacks | Drug therapy | Mortality | Coronary vessels | Valine/administration & dosage/analogs & derivatives/therapeutic use | Angina Pectoris/prevention & control | dosage/therapeutic use | Cardiovascular Diseases/mortality/prevention & control | Myocardial Infarction/complications/drug therapy/prevention & control | Drug Therapy | Angiotensin-Converting Enzyme Inhibitors/administration | Atherosclerosis/complications | Captopril/administration & dosage/therapeutic use | Kardiologi | Cardiac and Cardiovascular Systems | Randomized Controlled Trials | Combination | Tetrazoles/administration & dosage/therapeutic use | Cerebrovascular Accident/prevention & control | Angiotensin II Type 1 Receptor Blockers/administration
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 04/2013, Volume 706, Issue 1-3, pp. 92 - 97
Recent experimental data suggest that certain angiotensin-converting enzyme (ACE) inhibitors and angiotensin AT receptor antagonists may possess anticonvulsant... 
Electroconvulsions | Gabapentin | AT1 receptor antagonists | ACE inhibitors | Drug interactions | receptor antagonists | AT receptor antagonists | ORGANIC CATION TRANSPORTER | RECEPTOR ANTAGONISTS | ISOBOLOGRAPHIC ANALYSIS | MAXIMAL ELECTROSHOCK | ACE-INHIBITORS | SEIZURES | ANTICONVULSANT ACTIVITY | PHARMACOLOGY & PHARMACY | EPILEPSY | ANTIEPILEPTIC DRUGS | TIAGABINE | Motor Skills - drug effects | Amines - blood | Seizures - drug therapy | Anticonvulsants - administration & dosage | Male | gamma-Aminobutyric Acid - administration & dosage | Brain - metabolism | Seizures - physiopathology | Benzimidazoles - administration & dosage | Amines - administration & dosage | Cyclohexanecarboxylic Acids - blood | Drug Therapy, Combination | Enalapril - administration & dosage | Angiotensin II Type 1 Receptor Blockers - administration & dosage | gamma-Aminobutyric Acid - pharmacokinetics | Anticonvulsants - blood | Anticonvulsants - pharmacokinetics | Cyclohexanecarboxylic Acids - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Benzoates - administration & dosage | Captopril - administration & dosage | gamma-Aminobutyric Acid - blood | Animals | Amines - pharmacokinetics | Avoidance Learning - drug effects | Mice | Cyclohexanecarboxylic Acids - pharmacokinetics | Losartan - administration & dosage | Electroshock | Enzymes | Seizures (Medicine) | Captopril | Angiotensin
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 01/2018, Volume 119, Issue 1, pp. 926 - 937
Sympathetic overdrive, activation of renin angiotensin systems (RAS), and oxidative stress are vitally involved in the pathogenesis of hypertension and... 
angiotensin | 2‐kidney | 1‐clip | cardiovascular remodeling | hypertension | 1-clip | 2-kidney | SYMPATHETIC AFFERENT REFLEX | ACTIVATION | SUPEROXIDE ANIONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | VASCULAR DYSFUNCTION | PLASMA-RENIN | ANGIOTENSIN-II | BLOOD-PRESSURE | CELL BIOLOGY | SALUSIN-BETA | INHIBITION | PARAVENTRICULAR NUCLEUS MEDIATE | Antihypertensive Agents - pharmacology | Reactive Oxygen Species - metabolism | Captopril - pharmacology | Angiotensin II - blood | Antihypertensive Agents - administration & dosage | Rats | Hypertension - drug therapy | Male | Glycosides - pharmacology | Renin - blood | Rats, Sprague-Dawley | Glycosides - administration & dosage | Hypertension - metabolism | Gene Expression Regulation - drug effects | Hypertension - blood | Captopril - administration & dosage | Norepinephrine - blood | Animals | Flavonoids - administration & dosage | Flavonoids - pharmacology | Oxidative Stress - drug effects | Ventricular Remodeling - drug effects | Disease Models, Animal | Hypertension | Prevention | Oxidases | Superoxide | Angiotensin | Heart | Oxidative stress | Syngeneic grafts | Pathogenesis | Body weight | Superoxide dismutase | Activation | Remodeling | Blood | NAD(P)H oxidase | Renin | Catalase | Rodents | Aorta | Blood pressure | Angiotensin II | Kidneys | Captopril | Ras protein | Malondialdehyde | Endothelial cells | Fibrosis | Myocardium | Norepinephrine | Ventricle | Hypertrophy
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/1992, Volume 327, Issue 10, pp. 678 - 684
BOTH the short-term and the long-term prognosis for patients with acute myocardial infarction has improved in recent years with the use of beta-adrenergic... 
CONVERTING ENZYME-INHIBITOR | MEDICINE, GENERAL & INTERNAL | THERAPY | LEFT-VENTRICULAR DYSFUNCTION | CONGESTIVE HEART-FAILURE | EXPANSION | RATS | DILATATION | EXERCISE | CAPTOPRIL
Journal Article
Hypertension, ISSN 0194-911X, 02/2014, Volume 63, Issue 2, pp. 273 - 280
Journal Article
Journal of Anesthesia, ISSN 0913-8668, 2/2015, Volume 29, Issue 1, pp. 65 - 77
Journal Article
Radiation Research, ISSN 0033-7587, 2014, Volume 181, Issue 5, pp. 464 - 470
Metformin, a biguanide drug used in the treatment of type II diabetes, was evaluated alone and in combination with amifostine, captopril, MESNA or... 
CELLS | SOD2 MNSOD | DNA-DAMAGE | DELAYED RADIOPROTECTION | CANCER | BIOPHYSICS | B-MEDIATED INDUCTION | MANGANESE SUPEROXIDE-DISMUTASE | BIOLOGY | AMPK | AGENTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | EXPOSURE | Free Radical Scavengers - pharmacology | Sulfhydryl Compounds - administration & dosage | Amifostine - pharmacology | Metformin - therapeutic use | Captopril - pharmacology | Sulfhydryl Compounds - pharmacology | Humans | Radiation-Protective Agents - administration & dosage | Mesna - therapeutic use | Captopril - therapeutic use | Radiation Injuries, Experimental - prevention & control | Acute Radiation Syndrome - pathology | Radiation-Protective Agents - pharmacology | Colony-Forming Units Assay | Free Radical Scavengers - therapeutic use | Acetylcysteine - therapeutic use | Metformin - administration & dosage | Acetylcysteine - administration & dosage | Drug Evaluation, Preclinical | Mesna - administration & dosage | Acute Radiation Syndrome - prevention & control | Mesna - pharmacology | Metformin - pharmacology | Mice, Inbred C57BL | Cells, Cultured | Free Radical Scavengers - administration & dosage | Endothelial Cells - radiation effects | Radiation Injuries, Experimental - pathology | Sarcoma - pathology | Mice, Inbred C3H | Drug Synergism | Captopril - administration & dosage | Animals | Fibroblasts - radiation effects | Fibroblasts - drug effects | Amifostine - administration & dosage | Cell Line, Tumor | Radiation-Protective Agents - therapeutic use | Amifostine - therapeutic use | Mice | Sulfhydryl Compounds - therapeutic use | Cell Line, Transformed | Endothelial Cells - drug effects
Journal Article